FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On December 1, 2006
Table of Contents
Docket # Title
1978N-0065 Skin Bleaching Drug Products
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
2006E-0488 Patent Extension Application for Isolex 300 (Human Stem Cells and Monoclonal Antibodies), U.S. Patent No. 4,965,204
2006E-0489 Patent Extension Application for Isolex 300 (Human Stem Cells and Monoclonal Antibodies), U.S. Patent No. 5,130,144
2006N-0277 Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006N-0414 Suicidality Data from Adult Antidepressant Trials
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006P-0491 make a determination that the withdrawal of the Reference Listed Drug (RLD), Psorcon E (diflorasone diacetate oin tment) Emollient , Ointment, 0.05%, was not for safety or effectiveness reasons.
1978N-0065 Skin Bleaching Drug Products
EC 102 Mrs. C. Denise Wright Vol #: 14
EC 103 American Society for Dermatologic Surgery Vol #: 14
1995S-0316 75-Day Premarket Notifications for New Dietary Ingredients
RPT 362 JML Marketing Inc Vol #: 270
RPT 363 TJ Panorama Inc Vol #: 270
RPT 364 SK Chemical Co., Ltd Vol #: 283
RPT 365 JML Marketing Inc Vol #: 270
2005N-0403 Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs
EC 7 QA Vol #: 3
EC 8 Ben Venue Laboratories, Inc. Vol #: 3
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
EC 2395
Attachment
Self Vol #: 10
EC 2396 Mr. Dan Waters Vol #: 10
EC 2397 Mr. Steveb O'Hara Vol #: 10
EC 2398 Ms. Frances DaGrossa Vol #: 10
EC 2399 Mr. Kevin Mark Vol #: 10
EC 2400 Mr. Jason R. Johnson Vol #: 10
EC 2401 Mrs. Bonnie Hillary Vol #: 10
EC 2402 Mrs. Celia Rico Vol #: 10
EC 2403 Mrs. Dianna DeBarberie Vol #: 10
EC 2404 Mr. George Lightner Vol #: 10
EC 2405 Mrs. Pamela Sherstad Vol #: 10
EC 2406 Mr. Miguel corbaton Vol #: 10
EC 2407 Mr. Mike Orradre Vol #: 10
EC 2408 Ms. Rita Deniger Vol #: 10
EC 2409 Mr. Ron and Sandra Grefke Vol #: 10
EC 2410 Hospital of St Raphael Vol #: 10
EC 2411 Mrs. Valerie Porter Vol #: 10
EC 2412 Mrs. Peggy Schlitz Vol #: 10
EC 2413 Ms. Diane Conover Vol #: 10
EC 2414 Mrs. Shirley Livingston Vol #: 10
EC 2415 Mrs. Deborah Stennett Vol #: 10
EC 2416 Miss. Karen Gardner Vol #: 10
EC 2417 Mrs. Maria O'Rourke Vol #: 10
EC 2418 Ms. Marsha Kettering Vol #: 10
EC 2419 Mrs. Tammy Earl Vol #: 10
EC 2420 Mrs. Jeri Dubbert Vol #: 10
EC 2421 Mrs. Joyce Bickel Vol #: 10
EC 2422 Mrs. Miki Jarvie Vol #: 10
EC 2423 Mr. Mike Shevy Vol #: 10
EC 2424 Mrs. Joanne Savage Vol #: 10
EC 2425 Mr. Kenneth Nowak Vol #: 10
EC 2426 Benedictine College Vol #: 10
EC 2427 Mrs. Helen Wilcox Vol #: 10
EC 2428 Mrs. Leticia Rosas Vol #: 10
EC 2429 Mr. Bruce Ludwick, Jr. Vol #: 10
EC 2430 Mrs. Stacy Middaugh Vol #: 10
EC 2431 Mr. Casey Truelove Vol #: 10
EC 2432 Mr. Jason Jones Vol #: 10
EC 2433 Jesus Through Mary Foundation Vol #: 10
EC 2434 Mr. Myron Kralis Vol #: 10
EC 2435 Mrs. Sharon Harrigan Vol #: 10
EC 2436 Mr. Jeffrey Jones Vol #: 10
EC 2437 Mr. Clifford Meier Vol #: 10
EC 2438 Mrs. Mary Keller Vol #: 10
EC 2439 none Vol #: 10
EC 2440 Mr. John Kilikevicius Vol #: 10
EC 2441 Mr. Kevin Costello Vol #: 10
EC 2442 Mrs. Carol Baron Vol #: 10
EC 2443 Mrs. Jennifer Sammons Vol #: 10
EC 2444 Mrs. Kimberly Neumaier Vol #: 10
EC 2445 Mrs. Karen Schooley Vol #: 10
2006E-0488 Patent Extension Application for Isolex 300 (Human Stem Cells and Monoclonal Antibodies), U.S. Patent No. 4,965,204
APP 1 The Johns Hopkins University Vol #: 1
2006E-0489 Patent Extension Application for Isolex 300 (Human Stem Cells and Monoclonal Antibodies), U.S. Patent No. 5,130,144
APP 1 The Johns Hopkins University Vol #: 1
LET 1 U.S. Patent and Trademark Office to FDA/CDER Vol #: 1
2006N-0277 Agency Information Collection Activities; Proposed Collection; Comment Request; Food Labeling; Notification Procedures for Statements on Dietary Supplements
N 2 FDA Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
C 711 D. Madronero Vol #: 28
C 712 J. Bryan Vol #: 28
C 713 Dr. B. Zander Vol #: 28
C 714 Woman's Voices for the Earth Vol #: 28
C 715 R. Kopitzke Vol #: 28
C 716 Consumers for Dental Choice Vol #: 28
C 717 R. Dudley, PhD Vol #: 28
C 718 F. MArtinez Vol #: 28
C 719 S. Farrell Vol #: 28
C 720 N. Shapka B.Sc., D.D.S. Vol #: 28
C 721 IAOMT Vol #: 28
C 722 L. Lewis Vol #: 28
C 723 R. Taylor Vol #: 28
C 724 M and J Impellizzeri Vol #: 28
C 725 M. LAmbert Vol #: 28
C 726 R. Whittinghill Vol #: 28
C 727 L. Hopkins Vol #: 28
C 728 M. Sunanda Vol #: 28
C 729 S. Taylor Vol #: 28
C 730 D. Kennedy, DDS Vol #: 28
C 731 C. Mannhardt, RN, BSN Vol #: 28
C 732 Dr. BAttey Vol #: 28
C 733 J. Elliott Vol #: 28
C 734 B. Wilkie Vol #: 28
C 735 J. Elliott Vol #: 28
C 736 R. Firebaugn Vol #: 28
C 737 S. Lumsden Vol #: 28
C 738 B and D Buckel Vol #: 28
C 739 Consumers for Dental Choice Vol #: 28
C 740 K. Martin Vol #: 28
C 741 K. Kennedy Vol #: 28
C 742 F. Koss Vol #: 28
C 743 L. Salzer Vol #: 28
C 744 S. Frye Vol #: 28
C 745 B. Hartmann, L.Ac. Vol #: 28
C 746 M. Wilson Vol #: 28
C 747 V. Cain, Jr. Vol #: 28
C 748 P. Smith Vol #: 28
C 749 F. Koss Vol #: 28
C 750 Dr. P. Gilbert Vol #: 28
C 751 S. Murray Vol #: 28
C 752 F. Koss Vol #: 28
C 753 L. Washburn Vol #: 28
C 754 C. Cave Vol #: 28
C 755 Dr. P. Daney Vol #: 28
C 756 D. Showalter Vol #: 28
C 757 M. Hageman Vol #: 28
C 758 Dr. M. Milburn Vol #: 28
C 759 M. Koerner Vol #: 28
C 760 K. Crawford Vol #: 28
C 761 J. Pennell Vol #: 28
C 762 J. Pennell Vol #: 28
C 763 N. Hokkanen Vol #: 28
C 764 H. Nguyen Vol #: 28
C 765 V. Varela, A.R.N.P. Vol #: 28
C 766 M. Porter Vol #: 28
C 767 A. Warn Vol #: 28
C 768 D. Wimberly Vol #: 28
C 769 Dr. J. Bromboz Vol #: 28
C 770 P. Nupponen, DMD, MAGD Vol #: 28
C 771 S. Easton Vol #: 28
C 772 No signature Vol #: 28
C 773 K. Ringo Vol #: 28
C 774 J. Hershman Vol #: 28
C 775 N. Oakes Vol #: 28
C 776 D. Moore, PhD Vol #: 28
C 777 M. Kane Vol #: 28
C 778 S. Hines Vol #: 28
C 779 N. Oakes Vol #: 28
C 780 L. Shein Vol #: 28
C 781 R and P. Golus Vol #: 28
C 782 Mission Possible International Vol #: 28
C 783 C. Rebman Vol #: 28
C 784 G. Alonzo Vol #: 28
C 785 K. Leavitt Vol #: 28
C 786 J. Duncan Vol #: 28
C 787 B. Shoaf Vol #: 28
C 788 S. Gikas Vol #: 28
C 789 M. Pytela Vol #: 28
C 790 T. Crocker Vol #: 28
C 791 E. Grow Vol #: 28
C 792 D. Rhoades Vol #: 28
C 793 Becky Vol #: 28
C 794 M. Lauvray Vol #: 28
C 795 E. Margalith Vol #: 28
C 796 L. Duda Vol #: 28
C 797 B. White Vol #: 28
C 798 S. Hines Vol #: 28
C 799 M and P Steele Vol #: 28
C 800 M. Burke Vol #: 28
C 801 No signature Vol #: 29
C 802 W. McMillan, DMD Vol #: 29
C 803 R. Holgers Vol #: 29
C 804 J. Milota Vol #: 29
C 805 W. Domb, DMD Vol #: 29
C 806 M. Thompson Vol #: 29
C 807 G. Marshall Vol #: 29
C 808 B. Rider Vol #: 29
C 809 DAMS, Intl Vol #: 29
C 810 N. Crosby Vol #: 29
C 811 G and J Marshall Vol #: 29
C 812 R. Petro Vol #: 29
C 813 R. Petro Vol #: 29
C 814 Jigsaw Health Foundation Vol #: 29
C 815 R. Howard Vol #: 29
C 816 L. Kowalis, RN Vol #: 29
C 817 E. Picard Vol #: 29
C 818 Consumers for Dental Choice Vol #: 29
C 819 T. Crocker Vol #: 29
C 820 D. Mariano Vol #: 29
C 821 J. Simpson Vol #: 29
C 822 H. Mylroie Vol #: 29
C 823 R. Kulacz, DDS Vol #: 29
C 824 N. Oakes Vol #: 29
C 825 D. Scire Vol #: 29
C 826 J. Malin Vol #: 29
C 827 M. Davis Vol #: 29
C 828 C. LArkin Vol #: 29
C 829 J. Johnson Vol #: 29
C 830 K. Orndorff Vol #: 29
2006N-0414 Suicidality Data from Adult Antidepressant Trials
EC 24 Mental Health America of Licking County Vol #: 1
EC 25
Attachment
Families for Depression Awareness Vol #: 1
EC 26 American Foundation for Suicide Prevention Vol #: 1
EC 27 Maryland Psychiatric Society Vol #: 1
EC 28 Mr. Eric Swan Vol #: 1
EC 29 University of Maryland School of Medicine Vol #: 1
EC 30 George Washington University MFA Vol #: 1
EC 31 Dr. Bernard Fischer Vol #: 1
EC 32 Pfizer Vol #: 1
EC 33 Main Street Community Mental Health Center Vol #: 1
EC 34 Ms. Mary Miles Vol #: 1
EC 35 Mrs. Suzanne Gonzalez Vol #: 1
EC 36 Mrs. Cynthia Schilf Vol #: 1
EC 37 Mark S. Komrad M.D. Vol #: 1
EC 38 American Foundation for Suicide Prevention Vol #: 1
EC 39 Mrs. donna stevens Vol #: 1
EC 40 Mrs. Annabel Dobbs Vol #: 1
EC 41 Mrs. Cathy Harter Vol #: 1
EC 42 Dr. Paulo Negro Vol #: 1
EC 43 Sheppard Pratt Health System Vol #: 1
EC 44 Mrs. Cassandra Dawn Casey Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
EC 432 Dr. Loretta Pesteanu Vol #: 7
2006P-0491 make a determination that the withdrawal of the Reference Listed Drug (RLD), Psorcon E (diflorasone diacetate oin tment) Emollient , Ointment, 0.05%, was not for safety or effectiveness reasons.
ACK 1 FDA / DDM to Kirkpatrick & Lockhart Nicholson Graham LLP Vol #: 1
CP 1 Kirkpatrick & Lockhart Nicholson Graham LLP Vol #: 1

Page created on January 16, 2007 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management